These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
683 related items for PubMed ID: 12379751
1. CD5+ T-cell/histiocyte-rich large B-cell lymphoma. Chang CC, Bunyi-Teopengco E, Eshoa C, Chitambar CR, Kampalath B. Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751 [Abstract] [Full Text] [Related]
2. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C. Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195 [Abstract] [Full Text] [Related]
3. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Manazza AD, Bonello L, Pagano M, Chiusa L, Novero D, Stacchini A, Martini G, Vitolo U, Tarella C, Inghirami G, Palestro G, Chiarle R. Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287 [Abstract] [Full Text] [Related]
4. Large B-cell lymphoma of thyroid. Two cases with a marginal zone distribution of the neoplastic cells. Higgins JP, Warnke RA. Am J Clin Pathol; 2000 Aug; 114(2):264-70. PubMed ID: 10941342 [Abstract] [Full Text] [Related]
8. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM. Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256 [Abstract] [Full Text] [Related]
9. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. Khalidi HS, Brynes RK, Browne P, Koo CH, Battifora H, Medeiros LJ. Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727 [Abstract] [Full Text] [Related]
10. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report. Niino D, Ohsaki K, Arakawa F, Watanabe J, Kimura Y, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Sugita Y, Ohshima K, Okamura T. Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612 [Abstract] [Full Text] [Related]
12. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Fraga M, Sánchez-Verde L, Forteza J, García-Rivero A, Piris MA. Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783 [Abstract] [Full Text] [Related]
13. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Skugor ND, Perić Z, Vrhovac R, Radić-Kristo D, Kardum-Skelin I, Jaksić B. Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757 [Abstract] [Full Text] [Related]
14. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ, Zhang QY, Chen DF, Guan XJ, Zhang BL, Ma J. Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [Abstract] [Full Text] [Related]
20. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM. J Clin Oncol; 2008 Oct 01; 26(28):4587-94. PubMed ID: 18662967 [Abstract] [Full Text] [Related] Page: [Next] [New Search]